262 related articles for article (PubMed ID: 33572108)
1. Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.
Kaarijärvi R; Kaljunen H; Ketola K
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572108
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.
Patel GK; Chugh N; Tripathi M
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547070
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of neuroendocrine prostate cancer.
de Kouchkovsky I; Chan E; Schloss C; Poehlein C; Aggarwal R
Prostate; 2024 Apr; 84(5):426-440. PubMed ID: 38173302
[TBL] [Abstract][Full Text] [Related]
4. Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression.
Wang Z; Zhao Y; An Z; Li W
Front Oncol; 2019; 9():1491. PubMed ID: 32039001
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Cellular Plasticity in Prostate Cancer Progression.
Tiwari R; Manzar N; Ateeq B
Front Mol Biosci; 2020; 7():130. PubMed ID: 32754615
[TBL] [Abstract][Full Text] [Related]
6. Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer.
Liu C; Chen B; Xu P; Yang J; Nip C; Wang L; Shen Y; Ning S; Shang Y; Corey E; Gao AC; Gestwicki J; Wei Q; Liu L
Res Sq; 2024 Mar; ():. PubMed ID: 38585965
[TBL] [Abstract][Full Text] [Related]
7. The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1.
Romero R; Chu T; González-Robles TJ; Smith P; Xie Y; Kaur H; Yoder S; Zhao H; Mao C; Kang W; Pulina MV; Lawrence KE; Gopalan A; Zaidi S; Yoo K; Choi J; Fan N; Gerstner O; Karthaus WR; DeStanchina E; Ruggles KV; Westcott PMK; Chaligné R; Pe'er D; Sawyers CL
bioRxiv; 2024 Apr; ():. PubMed ID: 38645223
[TBL] [Abstract][Full Text] [Related]
8. Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer.
Chen B; Xu P; Yang JC; Nip C; Wang L; Shen Y; Ning S; Shang Y; Corey E; Gao AC; Gestwicki JE; Wei Q; Liu L; Liu C
Oncogene; 2024 Jun; ():. PubMed ID: 38877132
[TBL] [Abstract][Full Text] [Related]
9. Microbiota and the landscape of the prostate tumor microenvironment.
Gupta KR; Kyprianou N
Am J Clin Exp Urol; 2023; 11(5):352-360. PubMed ID: 37941651
[TBL] [Abstract][Full Text] [Related]
10. Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies.
Zaidi S; Park J; Chan JM; Roudier MP; Zhao JL; Gopalan A; Wadosky KM; Patel RA; Sayar E; Karthaus WR; Henry Kates D; Chaudhary O; Xu T; Masilionis I; Mazutis L; Chaligné R; Obradovic A; Linkov I; Barlas A; Jungbluth A; Rekhtman N; Silber J; Manova-Todorova K; Watson PA; True LD; Morrissey CM; Scher HI; Rathkopf D; Morris MJ; Goodrich DW; Choi J; Nelson PS; Haffner MC; Sawyers CL
bioRxiv; 2024 Apr; ():. PubMed ID: 38645034
[TBL] [Abstract][Full Text] [Related]
11. Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.
Soundararajan R; Aparicio AM; Logothetis CJ; Mani SA; Maity SN
Front Oncol; 2018; 8():69. PubMed ID: 29600194
[TBL] [Abstract][Full Text] [Related]
12. Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Wen YC; Tram VTN; Chen WH; Li CH; Yeh HL; Thuy Dung PV; Jiang KC; Li HR; Huang J; Hsiao M; Chen WY; Liu YN
Cell Death Dis; 2024 Jan; 15(1):92. PubMed ID: 38287005
[No Abstract] [Full Text] [Related]
13. Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility.
Jing N; Du X; Liang Y; Tao Z; Bao S; Xiao H; Dong B; Gao WQ; Fang YX
J Exp Clin Cancer Res; 2024 Jun; 43(1):167. PubMed ID: 38877572
[No Abstract] [Full Text] [Related]
14. Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small.
Serritella AV; Beltran H; Lotan TL; VanderWeele DJ; Karzai F; Madan RA; Hussain M
Oncologist; 2024 Mar; 29(3):185-189. PubMed ID: 38206818
[TBL] [Abstract][Full Text] [Related]
15. Landolfi's Treatment of Cancer.
Med Exam (Phila); 1856 Sep; 12(141):562-564. PubMed ID: 38122030
[No Abstract] [Full Text] [Related]
16. Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases.
Zhang Q; Han Y; Zhang Y; Liu D; Ming J; Huang B; Qiu X
Front Oncol; 2020; 10():571308. PubMed ID: 33598420
[TBL] [Abstract][Full Text] [Related]
17. Treatment-emergent neuroendocrine prostate cancer with a germline
Pandya D; Shah M; Kaplan F; Martino C; Levy G; Kazanjian M; Batter S; Martignetti J; Frank RC
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608381
[TBL] [Abstract][Full Text] [Related]
18. De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.
Abdulfatah E; Reichert ZR; Davenport MS; Chinnaiyan AM; Dadhania V; Wang X; Mannan R; Kunju LP; Hollenbeck BK; Montgomery JS; Kaffenberger SD; Morgan TM; Alva AS; Palapattu GS; Vaishampayan UN; Alumkal JJ; Spratt DE; Udager AM; Mehra R
Med Oncol; 2021 Feb; 38(3):26. PubMed ID: 33586037
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional mediators of treatment resistance in lethal prostate cancer.
He MX; Cuoco MS; Crowdis J; Bosma-Moody A; Zhang Z; Bi K; Kanodia A; Su MJ; Ku SY; Garcia MM; Sweet AR; Rodman C; DelloStritto L; Silver R; Steinharter J; Shah P; Izar B; Walk NC; Burke KP; Bakouny Z; Tewari AK; Liu D; Camp SY; Vokes NI; Salari K; Park J; Vigneau S; Fong L; Russo JW; Yuan X; Balk SP; Beltran H; Rozenblatt-Rosen O; Regev A; Rotem A; Taplin ME; Van Allen EM
Nat Med; 2021 Mar; 27(3):426-433. PubMed ID: 33664492
[TBL] [Abstract][Full Text] [Related]
20. Androgen Receptor Signaling and the Emergence of Lethal Neuroendocrine Prostate Cancer With the Treatment-Induced Suppression of the Androgen Receptor: A Literature Review.
Dhavale M; Abdelaal MK; Alam ABMN; Blazin T; Mohammed LM; Prajapati D; Ballestas NP; Mostafa JA
Cureus; 2021 Feb; 13(2):e13402. PubMed ID: 33754118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
